Wire Stories
EdiGene Raises Approximately USD 62 Million in Series B Plus Financing and Expands Operation Locations to Advance and Scale Up Clinical Translation of Gene Editing Technologies
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc. (�Company�, or �EdiGene�), today announced the successful completion of an RMB 400 million (approximately USD 62...